167 related articles for article (PubMed ID: 37298475)
1. Structural and Biological Features of G-Quadruplex Aptamers as Promising Inhibitors of the STAT3 Signaling Pathway.
Esposito V; Benigno D; Bello I; Panza E; Bucci M; Virgilio A; Galeone A
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298475
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative Effects of the Aptamer d(GGGT)
Virgilio A; Pecoraro A; Benigno D; Russo A; Russo G; Esposito V; Galeone A
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682635
[TBL] [Abstract][Full Text] [Related]
3. Exploring New Potential Anticancer Activities of the G-Quadruplexes Formed by [(GTG
Virgilio A; Benigno D; Pecoraro A; Russo A; Russo G; Esposito V; Galeone A
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208896
[TBL] [Abstract][Full Text] [Related]
4. Thrombin binding aptamer analogues containing inversion of polarity sites endowed with antiproliferative and anti-motility properties against Calu-6 cells.
Esposito V; Russo A; Vellecco V; Bucci M; Russo G; Mayol L; Virgilio A; Galeone A
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2645-2650. PubMed ID: 30071274
[TBL] [Abstract][Full Text] [Related]
5. Backbone modified TBA analogues endowed with antiproliferative activity.
Esposito V; Russo A; Amato T; Varra M; Vellecco V; Bucci M; Russo G; Virgilio A; Galeone A
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1213-1221. PubMed ID: 27663232
[TBL] [Abstract][Full Text] [Related]
6. Multi-targeted effects of G4-aptamers and their antiproliferative activity against cancer cells.
Ogloblina AM; Khristich AN; Karpechenko NY; Semina SE; Belitsky GA; Dolinnaya NG; Yakubovskaya MG
Biochimie; 2018 Feb; 145():163-173. PubMed ID: 29208488
[TBL] [Abstract][Full Text] [Related]
7. Properties and Potential Antiproliferative Activity of Thrombin-Binding Aptamer (TBA) Derivatives with One or Two Additional G-Tetrads.
Benigno D; Virgilio A; Bello I; La Manna S; Vellecco V; Bucci M; Marasco D; Panza E; Esposito V; Galeone A
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499249
[TBL] [Abstract][Full Text] [Related]
8. uL3 Mediated Nucleolar Stress Pathway as a New Mechanism of Action of Antiproliferative G-quadruplex TBA Derivatives in Colon Cancer Cells.
Pecoraro A; Virgilio A; Esposito V; Galeone A; Russo G; Russo A
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32290083
[TBL] [Abstract][Full Text] [Related]
9. The "Janus face" of the thrombin binding aptamer: Investigating the anticoagulant and antiproliferative properties through straightforward chemical modifications.
Esposito V; Russo A; Amato T; Vellecco V; Bucci M; Mayol L; Russo G; Virgilio A; Galeone A
Bioorg Chem; 2018 Feb; 76():202-209. PubMed ID: 29190476
[TBL] [Abstract][Full Text] [Related]
10. Tuning the Polymorphism of the Anti-VEGF G-rich V7t1 Aptamer by Covalent Dimeric Constructs.
Riccardi C; Musumeci D; Platella C; Gaglione R; Arciello A; Montesarchio D
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183039
[TBL] [Abstract][Full Text] [Related]
11. Phthalocyanines for G-quadruplex aptamers binding.
Lopes-Nunes J; Carvalho J; Figueiredo J; Ramos CIV; Lourenço LMO; Tomé JPC; Neves MGPMS; Mergny JL; Queiroz JA; Salgado GF; Cruz C
Bioorg Chem; 2020 Jul; 100():103920. PubMed ID: 32413624
[TBL] [Abstract][Full Text] [Related]
12. Quinazoline Ligands Induce Cancer Cell Death through Selective STAT3 Inhibition and G-Quadruplex Stabilization.
Jamroskovic J; Doimo M; Chand K; Obi I; Kumar R; Brännström K; Hedenström M; Nath Das R; Akhunzianov A; Deiana M; Kasho K; Sulis Sato S; Pourbozorgi PL; Mason JE; Medini P; Öhlund D; Wanrooij S; Chorell E; Sabouri N
J Am Chem Soc; 2020 Feb; 142(6):2876-2888. PubMed ID: 31990532
[TBL] [Abstract][Full Text] [Related]
13. RNA G-quadruplex as supramolecular carrier for cancer-selective delivery.
Santos T; Pereira P; Campello MPC; Paulo A; Queiroz JA; Cabrita E; Cruz C
Eur J Pharm Biopharm; 2019 Sep; 142():473-479. PubMed ID: 31325486
[TBL] [Abstract][Full Text] [Related]
14. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
[TBL] [Abstract][Full Text] [Related]
15. Structural studies and biological evaluation of T30695 variants modified with single chiral glycerol-T reveal the importance of LEDGF/p75 for the aptamer anti-HIV-integrase activities.
Rivieccio E; Tartaglione L; Esposito V; Dell'Aversano C; Koneru PC; Scuotto M; Virgilio A; Mayol L; Kvaratskhelia M; Varra M
Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):351-361. PubMed ID: 30414444
[TBL] [Abstract][Full Text] [Related]
16. Expanding the potential of G-quadruplex structures: formation of a heterochiral TBA analogue.
Virgilio A; Varra M; Scuotto M; Capuozzo A; Irace C; Mayol L; Esposito V; Galeone A
Chembiochem; 2014 Mar; 15(5):652-5. PubMed ID: 24520055
[TBL] [Abstract][Full Text] [Related]
17. Computational study on mechanism of G-quartet oligonucleotide T40214 selectively targeting Stat3.
Zhu Q; Jing N
J Comput Aided Mol Des; 2007; 21(10-11):641-8. PubMed ID: 18034310
[TBL] [Abstract][Full Text] [Related]
18. G-quadruplex-based aptamers targeting human thrombin: Discovery, chemical modifications and antithrombotic effects.
Riccardi C; Napolitano E; Platella C; Musumeci D; Montesarchio D
Pharmacol Ther; 2021 Jan; 217():107649. PubMed ID: 32777331
[TBL] [Abstract][Full Text] [Related]
19. Structural properties and anticoagulant/cytotoxic activities of heterochiral enantiomeric thrombin binding aptamer (TBA) derivatives.
Virgilio A; Esposito V; Pecoraro A; Russo A; Vellecco V; Pepe A; Bucci M; Russo G; Galeone A
Nucleic Acids Res; 2020 Dec; 48(22):12556-12565. PubMed ID: 33270863
[TBL] [Abstract][Full Text] [Related]
20. G4 Aptamers: Trends in Structural Design.
Varizhuk A; Ilyinsky N; Smirnov I; Pozmogova G
Mini Rev Med Chem; 2016; 16(16):1321-1329. PubMed ID: 26996618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
